The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...

Artificial intelligence is getting really good at helping doctors diagnose problems and even discover new drugs faster. It ...

However, the research team head cautioned that it is still too early to recommend the mRNA COVID-19 vaccine as a standard part of cancer therapy.

RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.

Stone jauntily observes: "5 billion of us got Covid vaccines. Apparently we all have 2 months left to live. Better make the ...

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...

The breakthrough mRNA vaccine that enabled the world to fight Covid-19 may also be used to fight cancers of the lung or skin.

Even before its $250 million Hazelwood Green facility is finished in 2028, researchers are already making breakthroughs in biomanufacturing.

In the latest trading session, Moderna (MRNA) closed at $26.85, marking a -2.33% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.53%. Elsewhere, the Dow ...